S
SIMON FRASER UNIVERSITY
?
S.07-143
Senate Committee on University Priorities
?
Memorandum
TO:
Senate ?
FROM:
?
John Waterhouse.
Chair, SCUP
?
.'
Vice President,/Academic
RE: Merck Frosst LEEF Chair in ?
DATE: ?
November 13, 2007
Pharmaceutical Genomics and Bioinformatics
in Drug Discovery - Terms of Reference (SCUP 07-66)
At its November 7, 2007 meeting SCUP reviewed and approved the terms of reference
for the Merck Frosst LEEF Chair in Pharmaceutical Genomics and Bioinformatics in
Drug Discovery.
Motion
That Senate approve and recommend to the Board of Governors the terms of reference
for the Merck Frosst LEEF Chair in Pharmaceutical Genomics and Bioinformatics in
Drug Discovery.
Rationale
Due to the requirements of funding arrangements and administrative commitments
associated with the establishment of the BC Leading Edge Endowment Fund Chairs,
the first Chair holder is already in place at SFU. The delay in submitting these terms of
reference to Senate was a regrettable oversight associated with the LEEF Chairs not
following SFU's normal process for the establishment of such positions.
end.
c: M. Plischke
.
0
SCUP 07-66
I
S
TO: J.H. Waterhouse, VP Academic
?
FROM:
Dr. Michael Plischke, Dean
Faculty of Science
RE: Merck Frosst LEEF Chair in ?
DATE:
October 31, 2007
Pharmaceutical Genomics
&
Bioinfomatics in Drug Discovery.
Please find attached the terms for reference for the Merck Frosst LEEF Chair in
Pharmaceutical Genomics & Bloinfomatics in Drug Discovery.
•5)
Michael Plischke
0
?
T':.
4
Terms of Reference
?
Merck-Frosst BC Leadership Chair in Pharmaceutical Genomics and
Drug Discovery
The Merck-Frosst BC Leadership Chair in Pharmaceutical Genomics and Drug
Discovery was established at Simon Fraser University through a contribution of
$2,250,000 from the Province of BC's Leading Edge Endowment Fund, a naming
contribution of $1,000,000 from Merck-Frosst, Canada and other contributions that bring
the initial endowment to
$4,500,000.
This Fund will be held in perpetuity by Simon
Fraser University. The Chair will be a senior scientist who will lead a world-class
research program in pharmaceutical genomics and drug development. The Chair will
initially be housed in the Department of Chemistry, Faculty of Science.
The Appointment
1.
Simon Fraser University will conduct an international search for the most
outstanding candidate. The successful candidate will be appointed to a tenured
position at the rank of Professor according to the procedures of policy A10.06
(Appointment of Specially. Funded University Chairs, University Professors and
Research Fellows.)
2.
The initial appointment will be for a term of five years and will be renewable after
review, as mandated by policy A10.06.
3.
The committee charged with carrying out the search will be appointed by the
Dean of Science.
4.
The Chair will be expected to contribute to the undergraduate and graduate
teaching program of the University. The formal teaching load will be half of the
normal teaching load of faculty in the relevant department.
Fund Administration
1.
The administrator of the Fund will be the Vice-President, Academic or his or her
designate.
2.
The capital of the Endowment will be held in perpetuity with a portion of annual
earned income reinvested in the Endowment to protect its value over time.
3.
A portion of the annual earned income (see Endowment Management Policy GP
20) will be used to pay the Chair's salary and benefits. Any unused portion of this
earned income will be made available to the Chair for research.
4.
In the event that circumstances make the specified use of the Endowment no
longer practicable or desirable, the Board of Governors of Simon Fraser
University is hereby authorized to make any changes it may deem necessary in
the terms or use of the Endowment Fund of the Merck-Frosst BC Leadership
Chair in Pharmaceutical Genomics and Drug Discovery. However, such changes
will be in keeping, as far as possible, with the original spirit and intent of the BC
Leadership Chair Program.
3. ?
.
